Scarica l'app Stockscreener
117.50
0.47%
-0.385
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVTY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$117.88
Aprire:
$118.25
Volume 24 ore:
127.41K
Relative Volume:
0.09
Capitalizzazione di mercato:
$13.10B
Reddito:
$2.90B
Utile/perdita netta:
$239.11M
Rapporto P/E:
55.69
EPS:
2.1097
Flusso di cassa netto:
$492.62M
1 W Prestazione:
+2.70%
1M Prestazione:
+5.59%
6M Prestazione:
+22.17%
1 anno Prestazione:
+29.03%
Intervallo 1D:
$115.67
$118.34
Intervallo di 1 settimana:
$112.68
$118.34
Portata 52W:
$81.22
$118.34
Revvity Inc Stock (RVTY) Company Profile
Nome
Revvity Inc
Settore
Industria
Telefono
781-663-6900
Indirizzo
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, NTRA, IDXX, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
117.37 | 13.15B | 2.90B | 239.11M | 492.62M | 2.1097 |
TMO
Thermo Fisher Scientific Inc
|
602.08 | 222.96B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
204.87 | 144.67B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
313.39 | 45.54B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
567.57 | 44.95B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.89 | 41.87B | 7.23B | 1.41B | 1.09B | 4.979 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-14 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-12-09 | Iniziato | Goldman | Neutral |
| 2025-10-16 | Iniziato | Guggenheim | Neutral |
| 2025-05-01 | Aggiornamento | UBS | Neutral → Buy |
| 2025-01-10 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-07-08 | Iniziato | Leerink Partners | Outperform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | UBS | Buy → Neutral |
| 2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-23 | Ripresa | Goldman | Buy |
Mostra tutto
Revvity Inc Borsa (RVTY) Ultime notizie
Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Hold" by Analysts - MarketBeat
The Top 5 Analyst Questions From Revvity’s Q2 Earnings Call - Yahoo Finance
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo Finance
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Understanding the Setup: (RVTY) and Scalable Risk - Stock Traders Daily
RVTY SWOT Analysis: Strong Revenue Growth Amidst Market Challenges Revealed in 10-Q Filing - GuruFocus
Revvity : Quarterly Report for Quarter Ending July 5, 2026 (Form 10-Q) - marketscreener.com
Revvity (RVTY) grows Q2 revenue, boosts cash and plans China diagnostics exit - stocktitan.net
Revvity (RVTY) Q2 2026 Earnings Call Transcript - AOL.com
Revvity to Present at Upcoming Investor Conferences - Business Wire
Revvity, Inc. (RVTY) stock price, news, quote and history - Yahoo Finance UK
Revvity Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Revvity Launches Superflex Prenatal Screening System - marketscreener.com
Revvity, Inc. (RVTY) Stock Analysis: Healthcare Innovation With A 5.59% Upside - directorstalkinterviews.com
Bank of America Corp DE Increases Stake in Revvity Inc. $RVTY - MarketBeat
Revvity Q2 Earnings Call Highlights - TradingView
Will Raised 2026 Revenue Guidance and Diagnostics Strength Change Revvity's (RVTY) Narrative - webull.com
Revvity (NYSE:RVTY) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Revvity, Inc. (RVTY) Stock forecasts - Yahoo Finance UK
Revvity, Inc. (0KHE) Q3 2022 Earnings ReportResults, Call & Slides - tipranks.com
REVVITY, INC. : STIFEL RAISES TARGET PRICE TO $110 FROM $100 - webull.com
Revvity (NYSE:RVTY) Rating Increased to Hold at Zacks Research - MarketBeat
Does Revvity’s Q2 Beat, Higher Guidance and China Exit Alter the Bull Case for RVTY? - Yahoo Finance
Why Revvity (RVTY) Stock Is Up Today - The Globe and Mail
Stifel raises Revvity stock price target to $110 on earnings beat - Investing.com
REVVITY, INC. : JP MORGAN RAISES TARGET PRICE TO $110 FROM $90 - Moomoo
Revvity posts solid Q2 2026 earnings growth - The Globe and Mail
Amundi Sells 32,858 Shares of Revvity Inc. $RVTY - MarketBeat
Evercore ISI Adjusts Price Target on Revvity to $126 From $125, Maintains Outperform Rating - Yahoo Finance
Revvity, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Revvity Inc (RVTY) Shares Fall 3.3% -- What GF Score of 75 Tells Investors - GuruFocus
Revvity Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
No-Moat Revvity Sees Solid First-Half Performance With Momentum Likely to Continue - Morningstar
Revvity, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:RVTY) 2026-08-04 - Seeking Alpha
RVTY Q2 Earnings Beat Estimates on Diagnostics Strength, '26 View Up - Yahoo Finance
Earnings call transcript: Revvity beats Q2 2026 estimates, but shares fall premarket - Investing.com
Revvity Inc (RVTY) (Q2 2026) Earnings Call Highlights: Strong Di - GuruFocus
Revvity, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
Revvity (NYSE:RVTY) Issues FY 2026 Earnings Guidance - MarketBeat
Revvity, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 05, 2026 - marketscreener.com
Revvity raises annual profit, revenue forecasts on strong diagnostics demand - Yahoo! Finance Canada
Revvity Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Is Revvity Inc (RVTY) Undervalued? Q2 Earnings Report Shows GAAP - GuruFocus
Transcript: Revvity Q2 2026 Earnings Conference Call - Benzinga
Revvity Tops Second-Quarter Estimates and Lifts Full-Year Outlook - Yahoo Finance
Q2 2026 Revvity Inc Earnings Call Transcript - GuruFocus
Revvity (RVTY) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
Revvity beats estimates, raises guidance as stock jumps - Investing.com
Earnings Flash (RVTY) Revvity, Inc. Reports Q2 Revenue $729.7M, vs. FactSet Est of $703.0M - marketscreener.com
Earnings Flash (RVTY) Revvity, Inc. Posts Q2 Adjusted EPS $1.41 per Share, vs. FactSet Est of $1.21 - marketscreener.com
Revvity Q2 revenue rises to $730 million as company raises 2026 guidance - Quiver Quantitative
Revvity Inc Azioni (RVTY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.01%
0.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):